MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$274,610K
(17.94%↑ Y/Y)
Deferred income taxes
$93,248K
(1461.48%↑ Y/Y)
Depreciation and
amortization
$36,627K
(7.31%↑ Y/Y)
Share-based compensation
expense
$14,433K
(-9.33%↓ Y/Y)
Accounts payable
$7,136K
(590.45%↑ Y/Y)
Inventories
-$1,879K
(-110.13%↓ Y/Y)
Other
$1,753K
(2516.42%↑ Y/Y)
Provision for credit
losses
$1,619K
(21.09%↑ Y/Y)
Net cash provided by
operating activities
$402,340K
(82.82%↑ Y/Y)
Canceled cashflow
$28,965K
Net decrease in cash
and cash...
$43,572K
(146.87%↑ Y/Y)
Canceled cashflow
$358,768K
Other assets and
liabilities
$21,038K
(-67.16%↓ Y/Y)
Accounts receivable
$7,697K
(128.62%↑ Y/Y)
Deferred revenue
-$230K
(-10.05%↓ Y/Y)
Proceeds from exercises
of stock options...
$50,970K
(920.22%↑ Y/Y)
Proceeds from net
investment hedges
$349K
(-15.90%↓ Y/Y)
Net cash used by
financing activities
-$313,310K
(-7.67%↓ Y/Y)
Net cash used by
investing activities
-$44,871K
(-63.95%↓ Y/Y)
Net effect of
changes in exchange...
-$587K
(-111.05%↓ Y/Y)
Canceled cashflow
$50,970K
Canceled cashflow
$349K
Repurchases of common stock
$240,195K
(8.81%↑ Y/Y)
Borrowings under credit
facility, net
-$124,000K
Purchases of property and
equipment
$31,114K
(10.77%↑ Y/Y)
Acquisition of intangible
assets
$13,350K
Equity investments
$756K
Shares withheld for
statutory tax withholding...
$85K
(-61.01%↓ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
logo
IDEXX LABORATORIES INC DE (IDXX)
logo
IDEXX LABORATORIES INC DE (IDXX)